Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares

Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares

Compare this stock

IINN Stock Report Card

$

VolatilityTechnicalsSentimentProfitPerformanceEarnings

41%

Performance

Score:

10/100

IINN returned -8.60% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Sentiment

Score:

64/100

IINN had a bullish sentiment score of 63.94% across Twitter and StockTwits over the last 12 months. It had an average of 2.16 posts, 0.42 comments, and 2.10 likes per day.

Technicals

Score:

10/100

IINN receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.

Earnings

Score:

100/100

IINN has missed earnings 0 times in the last 20 quarters.

Profit

Score:

21/100

Out of the last 18 quarters, IINN has had 3 profitable quarters and has increased their profits year over year on 3 of them.

Volatility

Score:

40/100

IINN has had a lower than average amount of volatility over the last 12 months giving it a score of 40 of 100.

Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares Summary

Nasdaq / IINN
Healthcare
Medical - Devices
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.